Table 4

GEP-HN-LS test performance according to patient and cancer attributes
Patient/cancer attribute No. of specimens Overall PPA
Percent (ratio)
[95% Confidence Interval]
Age of Patient (years)
40-50 16 87.5 (14/16)
[61.7-98.4]
50-60 25 80.0 (20/25)
[59.3-93.2]
60-70 25 80.0 (20/25)
[59.3-93.2]
>70 10 90.0 (9/10)
[55.5-99.7]
Cancer Grade
Grade 1 4 100.0 (4/4)
[39.8-100.0]
Grade 2 10 80.0 (8/10)
[44.4-97.5]
Grade 3 56 82.1 (46/56)
[69.6-91.1]
Cancer Stage
I-II 16 75.0 (12/16)
[47.6-92.7]
III-IV 17 82.3 (14/17)
[56.6-96.2]
Primary Versus Metastatic Cancer
Metastatic 26 80.8 (21/26)
[60.6-93.4]
Primary 50 84.0 (42/50)
[70.9-92.8]
Biopsy Sites for Metastatic Cases
Lymph Node 21 81.0 (17/21)
[58.1-94.6]
Other 5 80.0 (4/5)
[28.4-99.5]

Abbreviations: PPA, positive percent agreement; No. of Specimens, Number of specimens in each category.

Lal et al.

Lal et al. Diagnostic Pathology 2013 8:44   doi:10.1186/1746-1596-8-44

Open Data